Author/Creator: Kang, In-Cheol - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Kang, In-Cheol

1. A novel small-molecule PPI inhibitor targeting integrin αvβ3-osteopontin interface blocks bone resorption in vitro and prevents bone loss in mice. (August 2016)

Authors:: Park, Doori; Park, Chan-Won; Choi, YoungJin; Lin, Jingjing; Seo, Dong-Hyun; Kim, Han-Sung; Lee, Soo Young; Kang, In-Cheol
Journal:: Biomaterials
Issue:: Volume 98(2016)
Page Start:: 131
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Corrigendum to "Antidepressant Effect of Fraxinus rhynchophylla Hance Extract in a Mouse Model of Chronic Stress-Induced Depression". (28th May 2019)

Authors:: Kim, Yu Ri; Park, Bo-Kyung; Kim, Young Hwa; Shim, Insop; Kang, In-Cheol; Lee, Mi Young
Journal:: BioMed research international
Issue:: Volume 2019(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Inhibitory Effects of HangAmDan-B1 (HAD-B1) Combined With Afatinib on H1975 Lung Cancer Cell–Bearing Mice. (March 2019)

Authors:: Kang, Hwa Jeong; Kim, Jeehye; Cho, Seong Hyeok; Park, So-Jung; Yoo, Hwa-Seung; Kang, In-Cheol
Journal:: Integrative cancer therapies
Issue:: Volume 18(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Synergistic Effect of HAD-B1 and Afatinib Against Gefitinib Resistance of Non-Small Cell Lung Cancer. (December 2022)

Authors:: Song, Si Yeon; Park, Ji Hye; Park, So-Jung; Kang, In-Cheol; Yoo, Hwa-Seung
Journal:: Integrative cancer therapies
Issue:: Volume 21(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗